FUREN Group Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares FUREN Group Pharmaceutical Co Ltd with three other
companies in this sector in CHINA :
Harbin Gloria Pharmaceuticals Co., Ltd
sales of 5.05 billion Chinese Renmimbi [US$724.57 million]
of which 81%
was Pharmaceutical Manufacturing),
Zhejiang Huahai Pharmaceutical
(5.39 billion Chinese Renmimbi [US$772.49 million]
of which 48%
was Drug Sale), and
(5.32 billion Chinese Renmimbi [US$762.45 million]
of which 100%
FUREN Group Pharmaceutical Co Ltd reported sales of 5.17 billion Chinese Renmimbi (US$741.20 million)
December of 2019.
decrease of 18.2%
versus 2018, when the company's sales were 6.32 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 23.3% decline
in Pharmaceutical Business, from 1.16 billion Chinese Renmimbi to 890.11 million Chinese Renmimbi.
There were also decreases in sales in
Pharmaceutical Industry (down 15.3% to 4.28 billion Chinese Renmimbi)